カテゴリー： Market Monitor Global, 世界, 医療/バイオ

非麻酔性鎮痛薬の世界市場見通し2023年-2029年

◆英語タイトル：Nonnarcotic Analgesics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5812）◆商品コード：MMG23JU5812
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：126
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Nonnarcotic Analgesics Market 調査レポートは次の情報を含め、グローバルにおけるの非麻酔性鎮痛薬市場規模と予測を収録しています。・世界の非麻酔性鎮痛薬市場：売上、2018年-2023年、2024年-2029年
・世界の非麻酔性鎮痛薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非麻酔性鎮痛薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「サリチル酸塩」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

非麻酔性鎮痛薬のグローバル主要企業は、GlaxoSmithKline Consumer Healthcare、 Bayer Corporation、 Atnahs Pharma、 Baudax Bio、 Prestige Brands, Inc.、 Cumberland Pharmaceuticals, Inc.、 Takeda Pharmaceutical Company、 Pfizer Inc.、 McNeil Consumer Healthcare、 Eli Lilly and Company、 Sun Pharmaceutical Industries、 Validus Pharmaceuticals、 Novartis Consumer Health、 Pacira Pharmaceuticals, Inc.、 Almatica Pharma、 Actavis、 Arbor Pharmaceuticals, LLC、 PLx Pharma Inc.、 Heron Therapeutics、 Assertio Therapeutics, Inc.、 Zyla Life Sciences、 Jazz Pharmaceuticals plcなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、非麻酔性鎮痛薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の非麻酔性鎮痛薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の非麻酔性鎮痛薬市場：タイプ別市場シェア、2022年
・サリチル酸塩、アニリン、ピラゾロン、その他有機酸

世界の非麻酔性鎮痛薬市場：用途別、2018年-2023年、2024年-2029年
世界の非麻酔性鎮痛薬市場：用途別市場シェア、2022年
・病院、薬局、専門診療所、その他

世界の非麻酔性鎮痛薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の非麻酔性鎮痛薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における非麻酔性鎮痛薬のグローバル売上、2018年-2023年
・主要企業における非麻酔性鎮痛薬のグローバル売上シェア、2022年
・主要企業における非麻酔性鎮痛薬のグローバル販売量、2018年-2023年
・主要企業における非麻酔性鎮痛薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GlaxoSmithKline Consumer Healthcare、 Bayer Corporation、 Atnahs Pharma、 Baudax Bio、 Prestige Brands, Inc.、 Cumberland Pharmaceuticals, Inc.、 Takeda Pharmaceutical Company、 Pfizer Inc.、 McNeil Consumer Healthcare、 Eli Lilly and Company、 Sun Pharmaceutical Industries、 Validus Pharmaceuticals、 Novartis Consumer Health、 Pacira Pharmaceuticals, Inc.、 Almatica Pharma、 Actavis、 Arbor Pharmaceuticals, LLC、 PLx Pharma Inc.、 Heron Therapeutics、 Assertio Therapeutics, Inc.、 Zyla Life Sciences、 Jazz Pharmaceuticals plc

*************************************************************

・調査・分析レポートの概要
非麻酔性鎮痛薬市場の定義
市場セグメント
世界の非麻酔性鎮痛薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非麻酔性鎮痛薬市場規模
世界の非麻酔性鎮痛薬市場規模：2022年 VS 2029年
世界の非麻酔性鎮痛薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非麻酔性鎮痛薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非麻酔性鎮痛薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：サリチル酸塩、アニリン、ピラゾロン、その他有機酸
非麻酔性鎮痛薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局、専門診療所、その他
非麻酔性鎮痛薬の用途別グローバル売上・予測

・地域別市場分析
地域別非麻酔性鎮痛薬市場規模 2022年と2029年
地域別非麻酔性鎮痛薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline Consumer Healthcare、 Bayer Corporation、 Atnahs Pharma、 Baudax Bio、 Prestige Brands, Inc.、 Cumberland Pharmaceuticals, Inc.、 Takeda Pharmaceutical Company、 Pfizer Inc.、 McNeil Consumer Healthcare、 Eli Lilly and Company、 Sun Pharmaceutical Industries、 Validus Pharmaceuticals、 Novartis Consumer Health、 Pacira Pharmaceuticals, Inc.、 Almatica Pharma、 Actavis、 Arbor Pharmaceuticals, LLC、 PLx Pharma Inc.、 Heron Therapeutics、 Assertio Therapeutics, Inc.、 Zyla Life Sciences、 Jazz Pharmaceuticals plc
...

Nonnarcotic analgesics refer to non steroidal anti-inflammatory drugs that have nothing to do with or have little to do with central opioid receptors
This report aims to provide a comprehensive presentation of the global market for Nonnarcotic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonnarcotic Analgesics. This report contains market size and forecasts of Nonnarcotic Analgesics in global, including the following market information:
Global Nonnarcotic Analgesics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nonnarcotic Analgesics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Nonnarcotic Analgesics companies in 2022 (%)
The global Nonnarcotic Analgesics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Salicylates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nonnarcotic Analgesics include GlaxoSmithKline Consumer Healthcare, Bayer Corporation, Atnahs Pharma, Baudax Bio, Prestige Brands, Inc., Cumberland Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Pfizer Inc. and McNeil Consumer Healthcare, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nonnarcotic Analgesics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonnarcotic Analgesics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nonnarcotic Analgesics Market Segment Percentages, by Type, 2022 (%)
Salicylates
Anilines
Pyrazolones
Other Organic Acids
Global Nonnarcotic Analgesics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nonnarcotic Analgesics Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Specialist Clinic
Other
Global Nonnarcotic Analgesics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Nonnarcotic Analgesics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nonnarcotic Analgesics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nonnarcotic Analgesics revenues share in global market, 2022 (%)
Key companies Nonnarcotic Analgesics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Nonnarcotic Analgesics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Consumer Healthcare
Bayer Corporation
Atnahs Pharma
Baudax Bio
Prestige Brands, Inc.
Cumberland Pharmaceuticals, Inc.
Takeda Pharmaceutical Company
Pfizer Inc.
McNeil Consumer Healthcare
Eli Lilly and Company
Sun Pharmaceutical Industries
Validus Pharmaceuticals
Novartis Consumer Health
Pacira Pharmaceuticals, Inc.
Almatica Pharma
Actavis
Arbor Pharmaceuticals, LLC
PLx Pharma Inc.
Heron Therapeutics
Assertio Therapeutics, Inc.
Zyla Life Sciences
Jazz Pharmaceuticals plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nonnarcotic Analgesics, market overview.
Chapter 2: Global Nonnarcotic Analgesics market size in revenue and volume.
Chapter 3: Detailed analysis of Nonnarcotic Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nonnarcotic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nonnarcotic Analgesics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Nonnarcotic Analgesics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonnarcotic Analgesics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonnarcotic Analgesics Overall Market Size
2.1 Global Nonnarcotic Analgesics Market Size: 2022 VS 2029
2.2 Global Nonnarcotic Analgesics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nonnarcotic Analgesics Sales: 2018-2029
3 Company Landscape
3.1 Top Nonnarcotic Analgesics Players in Global Market
3.2 Top Global Nonnarcotic Analgesics Companies Ranked by Revenue
3.3 Global Nonnarcotic Analgesics Revenue by Companies
3.4 Global Nonnarcotic Analgesics Sales by Companies
3.5 Global Nonnarcotic Analgesics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nonnarcotic Analgesics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nonnarcotic Analgesics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nonnarcotic Analgesics Players in Global Market
3.8.1 List of Global Tier 1 Nonnarcotic Analgesics Companies
3.8.2 List of Global Tier 2 and Tier 3 Nonnarcotic Analgesics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Nonnarcotic Analgesics Market Size Markets, 2022 & 2029
4.1.2 Salicylates
4.1.3 Anilines
4.1.4 Pyrazolones
4.1.5 Other Organic Acids
4.2 By Type – Global Nonnarcotic Analgesics Revenue & Forecasts
4.2.1 By Type – Global Nonnarcotic Analgesics Revenue, 2018-2023
4.2.2 By Type – Global Nonnarcotic Analgesics Revenue, 2024-2029
4.2.3 By Type – Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
4.3 By Type – Global Nonnarcotic Analgesics Sales & Forecasts
4.3.1 By Type – Global Nonnarcotic Analgesics Sales, 2018-2023
4.3.2 By Type – Global Nonnarcotic Analgesics Sales, 2024-2029
4.3.3 By Type – Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
4.4 By Type – Global Nonnarcotic Analgesics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nonnarcotic Analgesics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Specialist Clinic
5.1.5 Other
5.2 By Application – Global Nonnarcotic Analgesics Revenue & Forecasts
5.2.1 By Application – Global Nonnarcotic Analgesics Revenue, 2018-2023
5.2.2 By Application – Global Nonnarcotic Analgesics Revenue, 2024-2029
5.2.3 By Application – Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
5.3 By Application – Global Nonnarcotic Analgesics Sales & Forecasts
5.3.1 By Application – Global Nonnarcotic Analgesics Sales, 2018-2023
5.3.2 By Application – Global Nonnarcotic Analgesics Sales, 2024-2029
5.3.3 By Application – Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
5.4 By Application – Global Nonnarcotic Analgesics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Nonnarcotic Analgesics Market Size, 2022 & 2029
6.2 By Region – Global Nonnarcotic Analgesics Revenue & Forecasts
6.2.1 By Region – Global Nonnarcotic Analgesics Revenue, 2018-2023
6.2.2 By Region – Global Nonnarcotic Analgesics Revenue, 2024-2029
6.2.3 By Region – Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
6.3 By Region – Global Nonnarcotic Analgesics Sales & Forecasts
6.3.1 By Region – Global Nonnarcotic Analgesics Sales, 2018-2023
6.3.2 By Region – Global Nonnarcotic Analgesics Sales, 2024-2029
6.3.3 By Region – Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Nonnarcotic Analgesics Revenue, 2018-2029
6.4.2 By Country – North America Nonnarcotic Analgesics Sales, 2018-2029
6.4.3 US Nonnarcotic Analgesics Market Size, 2018-2029
6.4.4 Canada Nonnarcotic Analgesics Market Size, 2018-2029
6.4.5 Mexico Nonnarcotic Analgesics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Nonnarcotic Analgesics Revenue, 2018-2029
6.5.2 By Country – Europe Nonnarcotic Analgesics Sales, 2018-2029
6.5.3 Germany Nonnarcotic Analgesics Market Size, 2018-2029
6.5.4 France Nonnarcotic Analgesics Market Size, 2018-2029
6.5.5 U.K. Nonnarcotic Analgesics Market Size, 2018-2029
6.5.6 Italy Nonnarcotic Analgesics Market Size, 2018-2029
6.5.7 Russia Nonnarcotic Analgesics Market Size, 2018-2029
6.5.8 Nordic Countries Nonnarcotic Analgesics Market Size, 2018-2029
6.5.9 Benelux Nonnarcotic Analgesics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Nonnarcotic Analgesics Revenue, 2018-2029
6.6.2 By Region – Asia Nonnarcotic Analgesics Sales, 2018-2029
6.6.3 China Nonnarcotic Analgesics Market Size, 2018-2029
6.6.4 Japan Nonnarcotic Analgesics Market Size, 2018-2029
6.6.5 South Korea Nonnarcotic Analgesics Market Size, 2018-2029
6.6.6 Southeast Asia Nonnarcotic Analgesics Market Size, 2018-2029
6.6.7 India Nonnarcotic Analgesics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Nonnarcotic Analgesics Revenue, 2018-2029
6.7.2 By Country – South America Nonnarcotic Analgesics Sales, 2018-2029
6.7.3 Brazil Nonnarcotic Analgesics Market Size, 2018-2029
6.7.4 Argentina Nonnarcotic Analgesics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Nonnarcotic Analgesics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Nonnarcotic Analgesics Sales, 2018-2029
6.8.3 Turkey Nonnarcotic Analgesics Market Size, 2018-2029
6.8.4 Israel Nonnarcotic Analgesics Market Size, 2018-2029
6.8.5 Saudi Arabia Nonnarcotic Analgesics Market Size, 2018-2029
6.8.6 UAE Nonnarcotic Analgesics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline Consumer Healthcare
7.1.1 GlaxoSmithKline Consumer Healthcare Company Summary
7.1.2 GlaxoSmithKline Consumer Healthcare Business Overview
7.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Major Product Offerings
7.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Consumer Healthcare Key News & Latest Developments
7.2 Bayer Corporation
7.2.1 Bayer Corporation Company Summary
7.2.2 Bayer Corporation Business Overview
7.2.3 Bayer Corporation Nonnarcotic Analgesics Major Product Offerings
7.2.4 Bayer Corporation Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Corporation Key News & Latest Developments
7.3 Atnahs Pharma
7.3.1 Atnahs Pharma Company Summary
7.3.2 Atnahs Pharma Business Overview
7.3.3 Atnahs Pharma Nonnarcotic Analgesics Major Product Offerings
7.3.4 Atnahs Pharma Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.3.5 Atnahs Pharma Key News & Latest Developments
7.4 Baudax Bio
7.4.1 Baudax Bio Company Summary
7.4.2 Baudax Bio Business Overview
7.4.3 Baudax Bio Nonnarcotic Analgesics Major Product Offerings
7.4.4 Baudax Bio Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.4.5 Baudax Bio Key News & Latest Developments
7.5 Prestige Brands, Inc.
7.5.1 Prestige Brands, Inc. Company Summary
7.5.2 Prestige Brands, Inc. Business Overview
7.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Major Product Offerings
7.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.5.5 Prestige Brands, Inc. Key News & Latest Developments
7.6 Cumberland Pharmaceuticals, Inc.
7.6.1 Cumberland Pharmaceuticals, Inc. Company Summary
7.6.2 Cumberland Pharmaceuticals, Inc. Business Overview
7.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Major Product Offerings
7.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.6.5 Cumberland Pharmaceuticals, Inc. Key News & Latest Developments
7.7 Takeda Pharmaceutical Company
7.7.1 Takeda Pharmaceutical Company Company Summary
7.7.2 Takeda Pharmaceutical Company Business Overview
7.7.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Major Product Offerings
7.7.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.7.5 Takeda Pharmaceutical Company Key News & Latest Developments
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Company Summary
7.8.2 Pfizer Inc. Business Overview
7.8.3 Pfizer Inc. Nonnarcotic Analgesics Major Product Offerings
7.8.4 Pfizer Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Inc. Key News & Latest Developments
7.9 McNeil Consumer Healthcare
7.9.1 McNeil Consumer Healthcare Company Summary
7.9.2 McNeil Consumer Healthcare Business Overview
7.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Major Product Offerings
7.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.9.5 McNeil Consumer Healthcare Key News & Latest Developments
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Nonnarcotic Analgesics Major Product Offerings
7.10.4 Eli Lilly and Company Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly and Company Key News & Latest Developments
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Company Summary
7.11.2 Sun Pharmaceutical Industries Nonnarcotic Analgesics Business Overview
7.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.11.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.12 Validus Pharmaceuticals
7.12.1 Validus Pharmaceuticals Company Summary
7.12.2 Validus Pharmaceuticals Nonnarcotic Analgesics Business Overview
7.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Major Product Offerings
7.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.12.5 Validus Pharmaceuticals Key News & Latest Developments
7.13 Novartis Consumer Health
7.13.1 Novartis Consumer Health Company Summary
7.13.2 Novartis Consumer Health Nonnarcotic Analgesics Business Overview
7.13.3 Novartis Consumer Health Nonnarcotic Analgesics Major Product Offerings
7.13.4 Novartis Consumer Health Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.13.5 Novartis Consumer Health Key News & Latest Developments
7.14 Pacira Pharmaceuticals, Inc.
7.14.1 Pacira Pharmaceuticals, Inc. Company Summary
7.14.2 Pacira Pharmaceuticals, Inc. Business Overview
7.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Major Product Offerings
7.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.14.5 Pacira Pharmaceuticals, Inc. Key News & Latest Developments
7.15 Almatica Pharma
7.15.1 Almatica Pharma Company Summary
7.15.2 Almatica Pharma Business Overview
7.15.3 Almatica Pharma Nonnarcotic Analgesics Major Product Offerings
7.15.4 Almatica Pharma Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.15.5 Almatica Pharma Key News & Latest Developments
7.16 Actavis
7.16.1 Actavis Company Summary
7.16.2 Actavis Business Overview
7.16.3 Actavis Nonnarcotic Analgesics Major Product Offerings
7.16.4 Actavis Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.16.5 Actavis Key News & Latest Developments
7.17 Arbor Pharmaceuticals, LLC
7.17.1 Arbor Pharmaceuticals, LLC Company Summary
7.17.2 Arbor Pharmaceuticals, LLC Business Overview
7.17.3 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Major Product Offerings
7.17.4 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.17.5 Arbor Pharmaceuticals, LLC Key News & Latest Developments
7.18 PLx Pharma Inc.
7.18.1 PLx Pharma Inc. Company Summary
7.18.2 PLx Pharma Inc. Business Overview
7.18.3 PLx Pharma Inc. Nonnarcotic Analgesics Major Product Offerings
7.18.4 PLx Pharma Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.18.5 PLx Pharma Inc. Key News & Latest Developments
7.19 Heron Therapeutics
7.19.1 Heron Therapeutics Company Summary
7.19.2 Heron Therapeutics Business Overview
7.19.3 Heron Therapeutics Nonnarcotic Analgesics Major Product Offerings
7.19.4 Heron Therapeutics Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.19.5 Heron Therapeutics Key News & Latest Developments
7.20 Assertio Therapeutics, Inc.
7.20.1 Assertio Therapeutics, Inc. Company Summary
7.20.2 Assertio Therapeutics, Inc. Business Overview
7.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Major Product Offerings
7.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.20.5 Assertio Therapeutics, Inc. Key News & Latest Developments
7.21 Zyla Life Sciences
7.21.1 Zyla Life Sciences Company Summary
7.21.2 Zyla Life Sciences Business Overview
7.21.3 Zyla Life Sciences Nonnarcotic Analgesics Major Product Offerings
7.21.4 Zyla Life Sciences Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.21.5 Zyla Life Sciences Key News & Latest Developments
7.22 Jazz Pharmaceuticals plc
7.22.1 Jazz Pharmaceuticals plc Company Summary
7.22.2 Jazz Pharmaceuticals plc Business Overview
7.22.3 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Major Product Offerings
7.22.4 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Sales and Revenue in Global (2018-2023)
7.22.5 Jazz Pharmaceuticals plc Key News & Latest Developments
8 Global Nonnarcotic Analgesics Production Capacity, Analysis
8.1 Global Nonnarcotic Analgesics Production Capacity, 2018-2029
8.2 Nonnarcotic Analgesics Production Capacity of Key Manufacturers in Global Market
8.3 Global Nonnarcotic Analgesics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nonnarcotic Analgesics Supply Chain Analysis
10.1 Nonnarcotic Analgesics Industry Value Chain
10.2 Nonnarcotic Analgesics Upstream Market
10.3 Nonnarcotic Analgesics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nonnarcotic Analgesics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Nonnarcotic Analgesics in Global Market
Table 2. Top Nonnarcotic Analgesics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nonnarcotic Analgesics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nonnarcotic Analgesics Revenue Share by Companies, 2018-2023
Table 5. Global Nonnarcotic Analgesics Sales by Companies, (K Units), 2018-2023
Table 6. Global Nonnarcotic Analgesics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nonnarcotic Analgesics Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Nonnarcotic Analgesics Product Type
Table 9. List of Global Tier 1 Nonnarcotic Analgesics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nonnarcotic Analgesics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Nonnarcotic Analgesics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nonnarcotic Analgesics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nonnarcotic Analgesics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nonnarcotic Analgesics Sales (K Units), 2018-2023
Table 15. By Type - Global Nonnarcotic Analgesics Sales (K Units), 2024-2029
Table 16. By Application – Global Nonnarcotic Analgesics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nonnarcotic Analgesics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nonnarcotic Analgesics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nonnarcotic Analgesics Sales (K Units), 2018-2023
Table 20. By Application - Global Nonnarcotic Analgesics Sales (K Units), 2024-2029
Table 21. By Region – Global Nonnarcotic Analgesics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nonnarcotic Analgesics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nonnarcotic Analgesics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nonnarcotic Analgesics Sales (K Units), 2018-2023
Table 25. By Region - Global Nonnarcotic Analgesics Sales (K Units), 2024-2029
Table 26. By Country - North America Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nonnarcotic Analgesics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nonnarcotic Analgesics Sales, (K Units), 2018-2023
Table 29. By Country - North America Nonnarcotic Analgesics Sales, (K Units), 2024-2029
Table 30. By Country - Europe Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nonnarcotic Analgesics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nonnarcotic Analgesics Sales, (K Units), 2018-2023
Table 33. By Country - Europe Nonnarcotic Analgesics Sales, (K Units), 2024-2029
Table 34. By Region - Asia Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nonnarcotic Analgesics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nonnarcotic Analgesics Sales, (K Units), 2018-2023
Table 37. By Region - Asia Nonnarcotic Analgesics Sales, (K Units), 2024-2029
Table 38. By Country - South America Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nonnarcotic Analgesics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nonnarcotic Analgesics Sales, (K Units), 2018-2023
Table 41. By Country - South America Nonnarcotic Analgesics Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nonnarcotic Analgesics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nonnarcotic Analgesics Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Nonnarcotic Analgesics Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline Consumer Healthcare Company Summary
Table 47. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product Offerings
Table 48. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline Consumer Healthcare Key News & Latest Developments
Table 50. Bayer Corporation Company Summary
Table 51. Bayer Corporation Nonnarcotic Analgesics Product Offerings
Table 52. Bayer Corporation Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bayer Corporation Key News & Latest Developments
Table 54. Atnahs Pharma Company Summary
Table 55. Atnahs Pharma Nonnarcotic Analgesics Product Offerings
Table 56. Atnahs Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Atnahs Pharma Key News & Latest Developments
Table 58. Baudax Bio Company Summary
Table 59. Baudax Bio Nonnarcotic Analgesics Product Offerings
Table 60. Baudax Bio Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Baudax Bio Key News & Latest Developments
Table 62. Prestige Brands, Inc. Company Summary
Table 63. Prestige Brands, Inc. Nonnarcotic Analgesics Product Offerings
Table 64. Prestige Brands, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Prestige Brands, Inc. Key News & Latest Developments
Table 66. Cumberland Pharmaceuticals, Inc. Company Summary
Table 67. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Offerings
Table 68. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Cumberland Pharmaceuticals, Inc. Key News & Latest Developments
Table 70. Takeda Pharmaceutical Company Company Summary
Table 71. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product Offerings
Table 72. Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Takeda Pharmaceutical Company Key News & Latest Developments
Table 74. Pfizer Inc. Company Summary
Table 75. Pfizer Inc. Nonnarcotic Analgesics Product Offerings
Table 76. Pfizer Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Pfizer Inc. Key News & Latest Developments
Table 78. McNeil Consumer Healthcare Company Summary
Table 79. McNeil Consumer Healthcare Nonnarcotic Analgesics Product Offerings
Table 80. McNeil Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. McNeil Consumer Healthcare Key News & Latest Developments
Table 82. Eli Lilly and Company Company Summary
Table 83. Eli Lilly and Company Nonnarcotic Analgesics Product Offerings
Table 84. Eli Lilly and Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Eli Lilly and Company Key News & Latest Developments
Table 86. Sun Pharmaceutical Industries Company Summary
Table 87. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product Offerings
Table 88. Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Sun Pharmaceutical Industries Key News & Latest Developments
Table 90. Validus Pharmaceuticals Company Summary
Table 91. Validus Pharmaceuticals Nonnarcotic Analgesics Product Offerings
Table 92. Validus Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Validus Pharmaceuticals Key News & Latest Developments
Table 94. Novartis Consumer Health Company Summary
Table 95. Novartis Consumer Health Nonnarcotic Analgesics Product Offerings
Table 96. Novartis Consumer Health Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Novartis Consumer Health Key News & Latest Developments
Table 98. Pacira Pharmaceuticals, Inc. Company Summary
Table 99. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product Offerings
Table 100. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Pacira Pharmaceuticals, Inc. Key News & Latest Developments
Table 102. Almatica Pharma Company Summary
Table 103. Almatica Pharma Nonnarcotic Analgesics Product Offerings
Table 104. Almatica Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Almatica Pharma Key News & Latest Developments
Table 106. Actavis Company Summary
Table 107. Actavis Nonnarcotic Analgesics Product Offerings
Table 108. Actavis Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Actavis Key News & Latest Developments
Table 110. Arbor Pharmaceuticals, LLC Company Summary
Table 111. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product Offerings
Table 112. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Arbor Pharmaceuticals, LLC Key News & Latest Developments
Table 114. PLx Pharma Inc. Company Summary
Table 115. PLx Pharma Inc. Nonnarcotic Analgesics Product Offerings
Table 116. PLx Pharma Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. PLx Pharma Inc. Key News & Latest Developments
Table 118. Heron Therapeutics Company Summary
Table 119. Heron Therapeutics Nonnarcotic Analgesics Product Offerings
Table 120. Heron Therapeutics Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Heron Therapeutics Key News & Latest Developments
Table 122. Assertio Therapeutics, Inc. Company Summary
Table 123. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product Offerings
Table 124. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Assertio Therapeutics, Inc. Key News & Latest Developments
Table 126. Zyla Life Sciences Company Summary
Table 127. Zyla Life Sciences Nonnarcotic Analgesics Product Offerings
Table 128. Zyla Life Sciences Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 129. Zyla Life Sciences Key News & Latest Developments
Table 130. Jazz Pharmaceuticals plc Company Summary
Table 131. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product Offerings
Table 132. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 133. Jazz Pharmaceuticals plc Key News & Latest Developments
Table 134. Nonnarcotic Analgesics Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 135. Global Nonnarcotic Analgesics Capacity Market Share of Key Manufacturers, 2021-2023
Table 136. Global Nonnarcotic Analgesics Production by Region, 2018-2023 (K Units)
Table 137. Global Nonnarcotic Analgesics Production by Region, 2024-2029 (K Units)
Table 138. Nonnarcotic Analgesics Market Opportunities & Trends in Global Market
Table 139. Nonnarcotic Analgesics Market Drivers in Global Market
Table 140. Nonnarcotic Analgesics Market Restraints in Global Market
Table 141. Nonnarcotic Analgesics Raw Materials
Table 142. Nonnarcotic Analgesics Raw Materials Suppliers in Global Market
Table 143. Typical Nonnarcotic Analgesics Downstream
Table 144. Nonnarcotic Analgesics Downstream Clients in Global Market
Table 145. Nonnarcotic Analgesics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nonnarcotic Analgesics Segment by Type in 2022
Figure 2. Nonnarcotic Analgesics Segment by Application in 2022
Figure 3. Global Nonnarcotic Analgesics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nonnarcotic Analgesics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nonnarcotic Analgesics Revenue, 2018-2029 (US$, Mn)
Figure 7. Nonnarcotic Analgesics Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nonnarcotic Analgesics Revenue in 2022
Figure 9. By Type - Global Nonnarcotic Analgesics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 12. By Type - Global Nonnarcotic Analgesics Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Nonnarcotic Analgesics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 16. By Application - Global Nonnarcotic Analgesics Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Nonnarcotic Analgesics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nonnarcotic Analgesics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 21. By Country - North America Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 23. US Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 28. Germany Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 29. France Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 37. China Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 41. India Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 44. Brazil Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nonnarcotic Analgesics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nonnarcotic Analgesics Sales Market Share, 2018-2029
Figure 48. Turkey Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nonnarcotic Analgesics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nonnarcotic Analgesics Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Nonnarcotic Analgesics by Region, 2022 VS 2029
Figure 54. Nonnarcotic Analgesics Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 非麻酔性鎮痛薬の世界市場見通し2023年-2029年(Nonnarcotic Analgesics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 鎮痛剤の世界市場見通し2023年-2029年
  • 医薬品及び賦形剤の世界市場見通し2023年-2029年
  • 神経疾患治療薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆